Jiangsu Lanfeng Bio-chemical Co Ltd (002513) — Working Capital to Net Assets Ratio
Jiangsu Lanfeng Bio-chemical Co Ltd (002513) has a Working Capital to Net Assets ratio of -282.4% as of March 2026. Working capital of CN¥-982.30 Million (current assets of CN¥2.01 Billion minus current liabilities of CN¥2.99 Billion) is measured against net assets of CN¥347.80 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jiangsu Lanfeng Bio-chemical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jiangsu Lanfeng Bio-chemical Co Ltd Working Capital to Net Assets (2007–2025)
This chart shows how Jiangsu Lanfeng Bio-chemical Co Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at -282.4%, reflecting working capital of CN¥-982.30 Million against net assets of CN¥347.80 Million CNY. For the complete balance sheet picture, see Jiangsu Lanfeng Bio-chemical Co Ltd balance sheet assets.
Annual Working Capital to Net Assets for Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Jiangsu Lanfeng Bio-chemical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -284.4% | CN¥-1.01 Billion | CN¥355.01 Million | CN¥2.30 Billion | CN¥3.31 Billion | ▲ +43.7 pp |
| 2024 | -328.1% | CN¥-1.03 Billion | CN¥312.58 Million | CN¥1.31 Billion | CN¥2.33 Billion | ▲ +47.7 pp |
| 2023 | -375.7% | CN¥-941.80 Million | CN¥250.66 Million | CN¥1.58 Billion | CN¥2.52 Billion | ▼ -186.5 pp |
| 2022 | -189.2% | CN¥-676.64 Million | CN¥357.59 Million | CN¥360.27 Million | CN¥1.04 Billion | ▼ -114.3 pp |
| 2021 | -74.9% | CN¥-499.20 Million | CN¥666.64 Million | CN¥546.04 Million | CN¥1.05 Billion | ▼ -48.1 pp |
| 2020 | -26.8% | CN¥-310.99 Million | CN¥1.16 Billion | CN¥822.94 Million | CN¥1.13 Billion | ▲ +26.5 pp |
| 2019 | -53.3% | CN¥-605.52 Million | CN¥1.14 Billion | CN¥814.77 Million | CN¥1.42 Billion | ▼ -36.9 pp |
| 2018 | -16.4% | CN¥-271.86 Million | CN¥1.66 Billion | CN¥1.31 Billion | CN¥1.58 Billion | ▼ -9.4 pp |
| 2017 | -7.0% | CN¥-177.30 Million | CN¥2.53 Billion | CN¥1.12 Billion | CN¥1.29 Billion | ▲ +1.9 pp |
| 2016 | -8.9% | CN¥-222.41 Million | CN¥2.51 Billion | CN¥1.09 Billion | CN¥1.31 Billion | ▲ +1.0 pp |
| 2015 | -9.8% | CN¥-236.58 Million | CN¥2.41 Billion | CN¥1.10 Billion | CN¥1.33 Billion | ▲ +15.1 pp |
| 2014 | -24.9% | CN¥-286.02 Million | CN¥1.15 Billion | CN¥753.36 Million | CN¥1.04 Billion | ▲ +9.8 pp |
| 2013 | -34.7% | CN¥-412.00 Million | CN¥1.19 Billion | CN¥846.49 Million | CN¥1.26 Billion | ▼ -12.0 pp |
| 2012 | -22.7% | CN¥-268.27 Million | CN¥1.18 Billion | CN¥866.63 Million | CN¥1.13 Billion | ▼ -45.0 pp |
| 2011 | 22.3% | CN¥253.92 Million | CN¥1.14 Billion | CN¥779.01 Million | CN¥525.09 Million | ▼ -44.6 pp |
| 2010 | 66.8% | CN¥720.44 Million | CN¥1.08 Billion | CN¥1.14 Billion | CN¥418.87 Million | ▲ +88.2 pp |
| 2009 | -21.4% | CN¥-52.00 Million | CN¥242.98 Million | CN¥262.07 Million | CN¥314.07 Million | ▲ +2.1 pp |
| 2008 | -23.5% | CN¥-42.50 Million | CN¥180.80 Million | CN¥214.61 Million | CN¥257.11 Million | ▲ +100.5 pp |
| 2007 | -124.0% | CN¥-97.30 Million | CN¥78.45 Million | CN¥170.50 Million | CN¥267.80 Million | — |